News for Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)

The sports medicine devices market size is anticipated to grow from USD 6.80 Billion in 2022 to USD 13.76 Billion in 10 years. The market ought to witness...

/PRNewswire/ -- The

Kubota Pharmaceutical Holdings  and its subsidiary Kubota Vision Inc. , an ophthalmic medical solutions company headquartered in Tokyo, launches its unique Kubota Glass technology, aiming to... | February 24, 2023

The Myopia Treatment Devices market is anticipated to boost as the demand for these devices is increasing at a considerable rate owing to the rising...

/PRNewswire/ -- The global sports medicine devices market is estimated to register growth at a CAGR of 5.6% during the forecast period, from 2021 to 2028,...

Belite Bio has filed proposed terms for a $36 million IPO. The firm is advancing treatment candidates for various eye diseases. Read more about the IPO here.

Belite Bio has filed to raise an undisclosed amount in an IPO. The firm is developing treatment candidates for eye diseases. Read more about BLTE's IPO here.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese... | August 12, 2021